1
|
Merlo-Mas J, Tomsen-Melero J, Corchero JL, González-Mira E, Font A, Pedersen JN, García-Aranda N, Cristóbal-Lecina E, Alcaina-Hernando M, Mendoza R, Garcia-Fruitós E, Lizarraga T, Resch S, Schimpel C, Falk A, Pulido D, Royo M, Schwartz S, Abasolo I, Pedersen JS, Danino D, Soldevila A, Veciana J, Sala S, Ventosa N, Córdoba A. Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method. J Supercrit Fluids 2021; 173:105204. [PMID: 34219919 PMCID: PMC8085735 DOI: 10.1016/j.supflu.2021.105204] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Robust preparation of liposomal formulation by DELOS-susp method. Implementation of Quality by Design methodology to liposomes preparation. Influence of critical parameters on quality was studied through DoE analysis. Design Space was obtained for GLA-loaded liposomes formulation.
Fabry disease is a lysosomal storage disease arising from a deficiency of the enzyme α-galactosidase A (GLA). The enzyme deficiency results in an accumulation of glycolipids, which over time, leads to cardiovascular, cerebrovascular, and renal disease, ultimately leading to death in the fourth or fifth decade of life. Currently, lysosomal storage disorders are treated by enzyme replacement therapy (ERT) through the direct administration of the missing enzyme to the patients. In view of their advantages as drug delivery systems, liposomes are increasingly being researched and utilized in the pharmaceutical, food and cosmetic industries, but one of the main barriers to market is their scalability. Depressurization of an Expanded Liquid Organic Solution into aqueous solution (DELOS-susp) is a compressed fluid-based method that allows the reproducible and scalable production of nanovesicular systems with remarkable physicochemical characteristics, in terms of homogeneity, morphology, and particle size. The objective of this work was to optimize and reach a suitable formulation for in vivo preclinical studies by implementing a Quality by Design (QbD) approach, a methodology recommended by the FDA and the EMA to develop robust drug manufacturing and control methods, to the preparation of α-galactosidase-loaded nanoliposomes (nanoGLA) for the treatment of Fabry disease. Through a risk analysis and a Design of Experiments (DoE), we obtained the Design Space in which GLA concentration and lipid concentration were found as critical parameters for achieving a stable nanoformulation. This Design Space allowed the optimization of the process to produce a nanoformulation suitable for in vivo preclinical testing.
Collapse
Key Words
- BCA, Bicinchoninic acid assay
- CMA, Critical Material Attributes
- CO2, Carbon dioxide
- CPP, Critical Process Parameters
- CQA, Critical Quality Attribute
- Chol, Cholesterol
- Chol-PEG400-RGD, Cholesterol pegylated with arginyl–glycyl–aspartic (RGD) acid peptide
- CoA, Certificate of Analysis
- Cryo-TEM, Cryogenic Transmission Electron Microscopy
- DELOS
- DELOS-susp, Depressurization of an Expanded Liquid Organic Solution into aqueous solution
- DLS, Dynamic Light Scattering
- DMSO, Dimethyl sulfoxide
- DPPC, 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
- DoE, Design of Experiments
- EA, Enzymatic Activity
- EE, Entrapment Efficiency
- EHS, Environment, Health and Safety
- EMA, European Medicines Agency
- ERT, Enzyme Replacement Therapy
- EtOH, Ethanol
- FDA, Food and Drug Administration
- Fabry disease
- GLA, α-galactosidase A enzyme
- H2O, Water
- HPLC, High Performance Liquid Chromatography
- ICH, Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- LSD, Lysosomal storage disorders
- MKC, Myristalkonium chloride
- N2, Nitrogen
- NTA, Nanoparticle Tracking Analysis
- PEG, Polyethylene Glycol
- PIC, Pressure Indicator Controller
- PLS, Partial Least Squares
- PdI, Polydispersity Index
- Protein-loaded liposomes
- Pw, Working pressure
- QbD, Quality by Design
- Quality by Design
- RGD, Arginine-Glycine-Aspartic acid
- S-MLS, Static Multiple Light Scattering
- SAXS, Small-Angle X-ray Scattering
- SDS-PAGE, Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
- SbD, Safe by Design
- Scale-up
- TFF, Tangential Flow Filtration
- TGX, Trys-Glycine eXtended
- TIC, Temperature Indicator Controller
- TSI, Turbiscan Stability Index
- Tw, Working temperature
- USP, United States Pharmacopeia
- XCO2, Carbon dioxide molar fraction
- fsingle, Ratio of monolayered liposomes
- nanoGLA, GLA-loaded nanoliposomes
- α-galactosidase
Collapse
Affiliation(s)
- Josep Merlo-Mas
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain
| | - Judit Tomsen-Melero
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain.,Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.,Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - José-Luis Corchero
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Institut de Biotecnologia i Biomedicina (IBB-UAB), 08193 Cerdanyola del Vallès, Spain
| | - Elisabet González-Mira
- Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.,Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | | | - Jannik N Pedersen
- Department of Chemistry and Interdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus, Aarhus C Denmark
| | - Natalia García-Aranda
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Functional Validation and Preclinical Research, Drug Delivery & Targeting, CIBBIM-Nanomedicina, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain
| | - Edgar Cristóbal-Lecina
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain
| | | | - Rosa Mendoza
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Institut de Biotecnologia i Biomedicina (IBB-UAB), 08193 Cerdanyola del Vallès, Spain
| | - Elena Garcia-Fruitós
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Institut de Biotecnologia i Biomedicina (IBB-UAB), 08193 Cerdanyola del Vallès, Spain
| | | | - Susanne Resch
- BioNanoNet Forschungsgesellschaft mbH, 8010 Graz, Austria
| | | | - Andreas Falk
- BioNanoNet Forschungsgesellschaft mbH, 8010 Graz, Austria
| | - Daniel Pulido
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain
| | - Miriam Royo
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain
| | - Simó Schwartz
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Functional Validation and Preclinical Research, Drug Delivery & Targeting, CIBBIM-Nanomedicina, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain
| | - Ibane Abasolo
- Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.,Functional Validation and Preclinical Research, Drug Delivery & Targeting, CIBBIM-Nanomedicina, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain
| | - Jan Skov Pedersen
- Department of Chemistry and Interdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000, Aarhus, Aarhus C Denmark
| | - Dganit Danino
- CryoEM Laboratory of Soft Matter, Faculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, 32000 Haifa, Israel
| | | | - Jaume Veciana
- Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.,Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Santi Sala
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain
| | - Nora Ventosa
- Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, 08193 Bellaterra, Spain.,Centro de Investigación Biomédica en Red - Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Alba Córdoba
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain
| |
Collapse
|
2
|
Cole SD, Miklos AE, Chiao AC, Sun ZZ, Lux MW. Methodologies for preparation of prokaryotic extracts for cell-free expression systems. Synth Syst Biotechnol 2020; 5:252-267. [PMID: 32775710 PMCID: PMC7398980 DOI: 10.1016/j.synbio.2020.07.006] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 07/22/2020] [Accepted: 07/23/2020] [Indexed: 12/19/2022] Open
Abstract
Cell-free systems that mimic essential cell functions, such as gene expression, have dramatically expanded in recent years, both in terms of applications and widespread adoption. Here we provide a review of cell-extract methods, with a specific focus on prokaryotic systems. Firstly, we describe the diversity of Escherichia coli genetic strains available and their corresponding utility. We then trace the history of cell-extract methodology over the past 20 years, showing key improvements that lower the entry level for new researchers. Next, we survey the rise of new prokaryotic cell-free systems, with associated methods, and the opportunities provided. Finally, we use this historical perspective to comment on the role of methodology improvements and highlight where further improvements may be possible.
Collapse
Affiliation(s)
- Stephanie D. Cole
- US Army Combat Capabilities Development Command Chemical Biological Center, 8567 Ricketts Point Road, Aberdeen Proving Ground, MD, 21010, USA
| | - Aleksandr E. Miklos
- US Army Combat Capabilities Development Command Chemical Biological Center, 8567 Ricketts Point Road, Aberdeen Proving Ground, MD, 21010, USA
| | - Abel C. Chiao
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA
- Synvitrobio Inc., San Francisco, CA, USA
| | - Zachary Z. Sun
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA
- Synvitrobio Inc., San Francisco, CA, USA
| | - Matthew W. Lux
- US Army Combat Capabilities Development Command Chemical Biological Center, 8567 Ricketts Point Road, Aberdeen Proving Ground, MD, 21010, USA
| |
Collapse
|